Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05434078 · ClinicalTrials.gov registry record · Phase 1
Orthofeet: A Prospective Proof of Concept Trial to Evaluate an Innovative Pain Relief Footwear
A Phase 1 study, sponsored by Bijan Najafi, PhD.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT05434078 is a Phase 1 study that has completed, run by Bijan Najafi, PhD. The registered enrollment target is 50 participants.
The verdict
NCT05434078, a Phase 1 study, has completed, sponsored by Bijan Najafi, PhD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this prospective randomized crossover study is to evaluate the effectiveness of a new pain relief footwear, Orthofeet, in reducing foot pain and improving daily physical activity. The investigators hypothesize that wearing Orthofeet shoes will lead to a reduction in foot pain, resulting in increased daily physical activity, objectively measured using validated wearable devices.
Interventions
- DEVICE Orthofeet Shoes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2024-08-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05434078
The ClinicalTrials.gov registry entry for NCT05434078 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bijan Najafi, PhD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Orthofeet Shoes is the first listed.
NCT05434078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05434078 about?
NCT05434078 is a clinical study titled "Orthofeet: A Prospective Proof of Concept Trial to Evaluate an Innovative Pain Relief Footwear". The purpose of this prospective randomized crossover study is to evaluate the effectiveness of a new pain relief footwear, Orthofeet, in reducing foot pain and improving daily physical activity. The investigators hypothesize that wearing Orthofeet shoes will lead to a reduction in foot pain, resulti...
What is the current status of trial NCT05434078?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2022-07-18. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT05434078?
The interventions under investigation include: Orthofeet Shoes (DEVICE).
Who is sponsoring clinical trial NCT05434078?
This trial is sponsored by Bijan Najafi, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.